Filing Details
- Accession Number:
- 0001209191-13-037017
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-17 16:39:24
- Reporting Period:
- 2013-07-15
- Filing Date:
- 2013-07-17
- Accepted Time:
- 2013-07-17 16:39:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1446372 | M Paul Silva | C/O Vertex Pharmaceuticals Incorporated 130 Waverly St. Cambridge MA 02139 | Svp & Corp Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-07-15 | 469 | $33.82 | 12,219 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-07-15 | 1,125 | $51.75 | 13,344 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-07-15 | 1,494 | $86.34 | 11,850 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-07-15 | 100 | $87.33 | 11,750 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-07-16 | 469 | $33.28 | 12,219 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-07-16 | 469 | $85.75 | 11,750 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2013-07-15 | 469 | $0.00 | 469 | $33.82 |
| Common Stock | Stock Option | Disposition | 2013-07-15 | 1,125 | $0.00 | 1,125 | $51.75 |
| Common Stock | Stock Option | Disposition | 2013-07-16 | 469 | $0.00 | 469 | $33.28 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,875 | 2020-07-13 | No | 4 | M | Direct | |
| 9,000 | 2021-07-12 | No | 4 | M | Direct | |
| 0 | 2019-07-15 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 169 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $86.34 (range $85.99 to $86.89).
- Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $85.75 (range $85.22 to $86.20).
- The option vests in 16 quarterly installments from 07/14/2010.
- The option vests in 16 quarterly installments from 07/13/2011.
- The option vests in 16 quarterly installments from 07/16/2009.
Billionaire Hedge Funds
